Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/8/2017
SIETES contiene 91969 citas

 
 
 1 a 20 de 25 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]
2.Tiene citas relacionadas Cita con resumen
Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff V, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom M, Corrao G, on behalf of the Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ 2016;354:i4857. [Ref.ID 100756]
3.Tiene citas relacionadas Cita con resumen
Gislason GH, Torp-Pedersen C. NSAIDs and the failing heart. BMJ 2016;354:i5163. [Ref.ID 100755]
4. Cita con resumen
Salvo F, Moore N, Arnaud M, Robinson P, Raschi E, De Ponti F, Bégaud B, Pariente A. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis. BMJ 2016;353:i2231. [Ref.ID 100309]
5. Cita con resumen
Chao TF, Liu CJ, Liao JN, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chen TJ, Lip GY, Chen SA. Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage. Circulation 2016;133:1540-7. [Ref.ID 100280]
6. Cita con resumen
Ezquerra Pérez G, Martín de la Nava MA, Álvarez-Cienfuegos A, Montaño Barrientos A, Baquero Barroso MJ, Rubio Núñez PL, Gómez Santana MC, Gavilán Moral E, Candela Marroquín E, Sánchez Robles GA. Revisión GRADE de estatinas en población con = 90% en prevención primaria cardiovascular. Sección 3: Efectos adversos. II. Miopatías.. Grupo Evalmed-GRADE 2016:21 de enero. [Ref.ID 99983]
7.Tiene citas relacionadas Cita con resumen
Wong AYS, Root A, Dogulas IJ, Chui CSL, Chan EW, Ghebremichael-Weldeselassie Y, Siu CW, Smeeth L, Wong ICK. Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ 2016;352:h6926. [Ref.ID 99982]
8.Tiene citas relacionadas Cita con resumen
Iyer G, Alexander GC. Cardiovascular risks associated with clarithromycin. BMJ 2016;352:i23. [Ref.ID 99980]
9. Cita con resumen
Jorgensen ME, Hlatky MA, Kober L, Sanders RD, Torp-Pedersen C, Gislason GH, Jensen PF, Andersson C. ß-blocker-associated risks in patients with uncomplicated hypertension undergoing noncardiac surgery. JAMA Intern Med 2015;175:1923-31. [Ref.ID 99749]
10.Tiene citas relacionadas Cita con resumen
Grey A, Bolland M. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ 2015;351:h3170. [Ref.ID 99391]
11. Cita con resumen
Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC. Antipsychotics, other psychotropics, and the risk of death in patients with dementia. Number needed to harm . JAMA Psychiatry 2015;72:438-45. [Ref.ID 98861]
12. Cita con resumen
van Kruijsdijk RCM, Visseren FLJ, Ridker PM, Dorresteijn JAN, Buring JE, Van der Graaf Y, Cook NR. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women . Heart 2014:4 de diciembre. [Ref.ID 98349]
13.Tiene citas relacionadas Cita con resumen
14. Cita con resumen
Abraham NS, Hartman C, Richardson P, Castillo D, Street Jr RL, Naik AD. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients. Circulation 2013;128:1869-77. [Ref.ID 96222]
15.Tiene citas relacionadas
Culver AL, Ockene IS, Ma Y. Statins and the risk of diabetes - Reply. Arch Intern Med 2012;172:896-7. [Ref.ID 93202]
16.Tiene citas relacionadas
Zeliger H. Statins and the risk of diabetes. Arch Intern Med 2012;172:896-7. [Ref.ID 93201]
17.Tiene citas relacionadas
Katsiki N, Banach M. Statins and the risk of diabetes: the debate. Arch Intern Med 2012;172:895-6. [Ref.ID 93200]
19.Tiene citas relacionadas Cita con resumen
Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, Manson JE, Qiao Y, Liu S, Merriam PA, Rahily-Tierny C, Thomas F, Berger JS, Ockene JK, Curb JD, Ma Y. Statin use and risk of diabetes mellitus in postmenopausal women in the women's health initiative. Arch Intern Med 2012;172:144-52. [Ref.ID 92271]
20. Cita con resumen
Preiss D, Seshasai SRK, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJP, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy. A meta-analysis. JAMA 2011;305:2556-64. [Ref.ID 91338]
Seleccionar todas
 
 1 a 20 de 25 siguiente >>